Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Clinical trial NCT05691491 · RECRUITING

Trial details

NCT number: NCT05691491
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Solid Neoplasm Advanced Microsatellite Stable Colorectal Carcinoma Hematopoietic and Lymphatic System Neoplasm Metastatic Malignant Solid Neoplasm Metastatic Microsatellite Stable Colorectal Carcinoma Stage III Colorectal Cancer AJCC v8 Stage IV Colorectal Cancer AJCC v8

Start date: 2023-09-28
Primary completion: 2027-03-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.